Suspension of trading

Income Statement Sirius XM Inc. Nasdaq

Stocks

LSXMK

US5312297899

Broadcasting

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-09 EDT			5-day change	1st Jan Change
22.29 ^USD	-1.15%		-.--%	-

25-03-27	Sirius XM Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-27	Formula One Group, Liberty Media Corporation, Q4 2024 Earnings Call, Feb 27, 2025

0d5a11ecc45edf9105f265baeb.WSCDoPDOrAMZK__xipFnk07J5zGFmU3qJednecBre-8.L3_T5aD35lB4SIal-udSpwGjqVa2wCybapExNp8nDoc3VuHjh_yBbFNIiA

Published financial data: SIRIUS XM INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.04B	8.7B	9B	8.95B	-
Other Revenues, Total	-	-	-	-	-
Total Revenues	8.04B	8.7B	9B	8.95B	-
Cost of Goods Sold, Total	3.94B	4.29B	4.48B	4.57B	-
Gross Profit	4.1B	4.4B	4.52B	4.38B	-
Selling General & Admin Expenses, Total	1.51B	1.6B	1.64B	1.53B	-
Stock-Based Compensation (IS)	-	36M	39M	46M	-
Depreciation & Amortization - (IS)	573M	603M	611M	624M	-
Other Operating Expenses	264M	212M	291M	276M	-
Other Operating Expenses, Total	2.35B	2.45B	2.58B	2.48B	-
Operating Income	1.75B	1.95B	1.94B	1.9B	-
Interest Expense, Total	-469M	-495M	-511M	-538M	-
Net Interest Expenses	-469M	-495M	-511M	-538M	-
Income (Loss) On Equity Invest.	-484M	-253M	67M	108M	-
Other Non Operating Income (Expenses)	-494M	-418M	468M	-190M	-
EBT, Excl. Unusual Items	306M	788M	1.97B	1.28B	-
Restructuring Charges	-	-25M	-	-64M	-
Merger & Related Restructuring Charges	-28M	-12M	-2M	-	-
Impairment of Goodwill	-956M	-	-	-	-
Gain (Loss) On Sale Of Investments	125M	273M	-9M	60M	-
Asset Writedown	-20M	-220M	-21M	-	-
Insurance Settlements	-	225M	-	-	-
Legal Settlements	-	-	-	-31M	-
Other Unusual Items	-40M	-80M	35M	18M	-
EBT, Incl. Unusual Items	-613M	949M	1.97B	1.27B	-
Income Tax Expense	106M	74M	467M	237M	-
Earnings From Continuing Operations	-719M	875M	1.5B	1.03B	-
Earnings Of Discontinued Operations	-	-	-	-	-2.41B
Net Income to Company	-719M	875M	1.5B	1.03B	-2.41B
Minority Interest	-28M	-276M	-210M	-202M	410M
Net Income - (IS)	-747M	599M	1.29B	829M	-2B
Net Income to Common Incl Extra Items	-747M	599M	1.29B	829M	-2B
Net Income to Common Excl. Extra Items	-747M	599M	1.29B	829M	410M
Per Share Items
Net EPS - Basic	-2.24	1.79	3.94	2.54	-6.12
Basic EPS - Continuing Operations	-2.24	1.79	3.94	2.54	1.25
Basic Weighted Average Shares Outstanding	334M	335M	328M	327M	327M
Net EPS - Diluted	-2.24	1.78	3.66	2.42	-5.89
Diluted EPS - Continuing Operations	-2.24	1.78	3.66	2.42	1.21
Diluted Weighted Average Shares Outstanding	334M	337M	345M	343M	340M
Normalized Basic EPS	0.49	0.65	3.11	1.84	1.25
Normalized Diluted EPS	0.49	0.64	2.95	1.75	1.21
Supplemental Items
EBITDA	2.33B	2.56B	2.55B	2.53B	-
EBITA	1.75B	1.95B	1.94B	1.9B	-
EBIT	1.75B	1.95B	1.94B	1.9B	-
Total Revenues (As Reported)	8.04B	8.7B	9B	8.95B	-
Effective Tax Rate - (Ratio)	-17.29	7.8	23.72	18.69	-
Current Domestic Taxes	66M	86M	138M	201M	-
Total Current Taxes	66M	86M	138M	201M	-
Deferred Domestic Taxes	40M	-12M	329M	36M	-
Total Deferred Taxes	40M	-12M	329M	36M	-
Normalized Net Income	163M	216M	1.02B	601M	410M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
Stock-Based Comp., COGS (Total)	44M	45M	46M	45M	-
Stock-Based Comp., SG&A Exp. (Total)	147M	134M	124M	112M	-
Stock-Based Comp., Other (Total)	-	36M	39M	46M	-
Total Stock-Based Compensation	191M	215M	209M	203M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	996M	598M	362M	306M	-
Short Term Investments	-	-	289M	-	-
Total Cash And Short Term Investments	996M	598M	651M	306M	-
Accounts Receivable, Total	672M	722M	669M	709M	-
Total Receivables	672M	722M	669M	709M	-
Restricted Cash	-	-	22M	-	-
Other Current Assets, Total	225M	793M	212M	346M	-
Total Current Assets	1.89B	2.11B	1.55B	1.36B	-
Gross Property Plant And Equipment	2.84B	2.81B	3.3B	3.1B	-
Accumulated Depreciation	-1.53B	-1.7B	-1.84B	-1.86B	-
Net Property Plant And Equipment	1.32B	1.11B	1.46B	1.24B	-
Long-term Investments	1.14B	1.18B	1.28B	856M	-
Goodwill	15.08B	15.11B	15.21B	15.21B	-
Other Intangibles, Total	11.31B	11.11B	10.94B	10.86B	-
Other Long-Term Assets, Total	1.33B	1.04B	33M	374M	-
Total Assets	32.08B	31.67B	30.48B	29.9B	-
Liabilities
Accounts Payable, Total	1.38B	1.46B	1.4B	1.47B	-
Current Portion of Long-Term Debt	475M	2.18B	1.54B	1.07B	-
Unearned Revenue Current, Total	1.72B	1.45B	1.32B	1.2B	-
Other Current Liabilities	420M	82M	75M	133M	-
Total Current Liabilities	4B	5.18B	4.34B	3.88B	-
Long-Term Debt	12.52B	12.08B	11.6B	10.06B	-
Long-Term Leases	-	-	-	-	-
Deferred Tax Liability Non Current	2.12B	2.21B	2.05B	2.24B	-
Other Non Current Liabilities	689M	611M	584M	526M	-
Total Liabilities	19.33B	20.07B	18.58B	16.71B	-
Common Stock, Total	8.25B	8.04B	8.76B	10.16B	-
Total Common Equity	8.25B	8.04B	8.76B	10.16B	-
Minority Interest	4.5B	3.56B	3.14B	3.03B	-
Total Equity	12.76B	11.6B	11.9B	13.19B	-
Total Liabilities And Equity	32.08B	31.67B	30.48B	29.9B	-
Supplemental Items
ECS Total Shares Outstanding on Filing Date	338M	333M	327M	327M	327M
ECS Total Common Shares Outstanding	339M	334M	327M	327M	327M
Book Value / Share	24.35	24.04	26.83	31.12	-
Tangible Book Value	-18.14B	-18.19B	-17.39B	-15.9B	-
Tangible Book Value Per Share	-53.56	-54.4	-53.27	-48.69	-
Total Debt	13B	14.26B	13.14B	11.14B	-
Net Debt	12B	13.66B	12.49B	10.83B	-
Minority Interest, Total (Incl. Fin. Div)	4.5B	3.56B	3.14B	3.03B	-
Equity Method Investments, Total	886M	805M	823M	715M	-
Account Code - Inventory Valuation	3	3	3	-	-
Full Time Employees	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-747M	599M	1.29B	829M	-2B
Depreciation & Amortization - CF	573M	603M	611M	624M	-
Depreciation & Amortization, Total	573M	603M	611M	624M	-
(Gain) Loss From Sale Of Asset	-	-	-4M	-	-
(Gain) Loss on Sale of Investments - (CF)	-4M	-152M	-10M	8M	-
Asset Writedown & Restructuring Costs	976M	24M	61M	24M	-
(Income) Loss On Equity Investments - (CF)	484M	253M	-67M	-108M	-
Stock-Based Compensation (CF)	234M	215M	209M	203M	-
Net Cash From Discontinued Operations	-	-	-	-	882M
Other Operating Activities, Total	555M	666M	114M	427M	2B
Change In Accounts Payable	-179M	-255M	-327M	-136M	-
Change in Other Net Operating Assets	32M	-59M	80M	-45M	-
Cash from Operations	1.92B	1.89B	1.96B	1.83B	882M
Capital Expenditure	-350M	-388M	-426M	-650M	-
Cash Acquisitions	-300M	-14M	-136M	-	-
Investment in Marketable and Equity Securities, Total	-96M	105M	66M	-50M	-
Other Investing Activities, Total	12M	233M	3M	4M	-709M
Cash from Investing	-734M	-64M	-493M	-696M	-709M
Short Term Debt Issued, Total	-	-	78M	-	-
Long-Term Debt Issued, Total	4.15B	6.29B	3.15B	2.68B	-
Total Debt Issued	4.15B	6.29B	3.23B	2.68B	-
Short Term Debt Repaid, Total	-750M	-	-	-	-
Long-Term Debt Repaid, Total	-2.2B	-5.87B	-3.55B	-3.78B	-
Total Debt Repaid	-2.95B	-5.87B	-3.55B	-3.78B	-
Issuance of Common Stock	754M	-	-	-	-
Repurchase of Common Stock	-365M	-606M	-505M	-64M	-
Other Financing Activities, Total	-2.27B	-2.05B	-872M	-20M	-488M
Cash from Financing	-689M	-2.23B	-1.7B	-1.18B	-488M
Foreign Exchange Rate Adjustments	-	-	-236M	-	-
Miscellaneous Cash Flow Adjustments	-	-	236M	-	-
Net Change in Cash	501M	-402M	-236M	-55M	-315M
Supplemental Items
Levered Free Cash Flow	1.46B	197M	1.11B	950M	-
Unlevered Free Cash Flow	1.76B	506M	1.43B	1.29B	-
Change In Net Working Capital	-248M	1.14B	178M	81M	-
Net Debt Issued / Repaid	1.2B	422M	-325M	-1.1B	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.45	3.83	3.91	3.94	-
Return on Total Capital	4.27	4.73	4.77	4.82	-
Return On Equity %	-4.95	7.18	12.78	8.22	-
Return on Common Equity	-7.89	7.36	15.39	8.76	-
Margin Analysis
Gross Profit Margin %	50.98	50.63	50.22	48.98	-
SG&A Margin	18.77	18.38	18.19	17.13	-
EBITDA Margin %	28.93	29.4	28.36	28.25	-
EBITA Margin %	21.8	22.47	21.57	21.28	-
EBIT Margin %	21.8	22.47	21.57	21.28	-
Income From Continuing Operations Margin %	-8.94	10.06	16.68	11.52	-
Net Income Margin %	-9.29	6.89	14.35	9.26	-
Net Avail. For Common Margin %	-9.29	6.89	14.35	9.26	-
Normalized Net Income Margin	2.03	2.49	11.32	6.71	-
Levered Free Cash Flow Margin	18.22	2.26	12.33	10.62	-
Unlevered Free Cash Flow Margin	21.86	5.82	15.88	14.37	-
Asset Turnover
Asset Turnover	0.25	0.27	0.29	0.3	-
Fixed Assets Turnover	6.02	7.16	6.05	7.58	-
Receivables Turnover (Average Receivables)	11.98	12.48	12.94	12.99	-
Short Term Liquidity
Current Ratio	0.47	0.41	0.36	0.35	-
Quick Ratio	0.42	0.25	0.3	0.26	-
Operating Cash Flow to Current Liabilities	0.48	0.37	0.45	0.47	-
Days Sales Outstanding (Average Receivables)	30.55	29.26	28.2	28.09	-
Average Days Payable Outstanding	124.17	120.65	116.58	115.02	-
Long Term Solvency
Total Debt/Equity	101.92	122.94	110.47	84.43	-
Total Debt / Total Capital	50.48	55.14	52.49	45.78	-
LT Debt/Equity	98.2	104.11	97.5	76.29	-
Long-Term Debt / Total Capital	48.63	46.7	46.33	41.36	-
Total Liabilities / Total Assets	60.24	63.37	60.97	55.88	-
EBIT / Interest Expense	3.74	3.95	3.8	3.54	-
EBITDA / Interest Expense	4.96	5.17	5	4.7	-
(EBITDA - Capex) / Interest Expense	4.21	4.38	4.16	3.49	-
Total Debt / EBITDA	5.59	5.58	5.15	4.4	-
Net Debt / EBITDA	5.16	5.34	4.89	4.28	-
Total Debt / (EBITDA - Capex)	6.58	6.58	6.18	5.93	-
Net Debt / (EBITDA - Capex)	6.07	6.3	5.87	5.76	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.16	8.16	3.53	-0.56	-
Gross Profit, 1 Yr. Growth %	4.04	7.84	2.68	-3.01	-
EBITDA, 1 Yr. Growth %	6.21	10.69	-0.16	-2.66	-
EBITA, 1 Yr. Growth %	6.05	12.49	-0.61	-4.13	-
EBIT, 1 Yr. Growth %	6.05	12.49	-0.61	-4.13	-
Earnings From Cont. Operations, 1 Yr. Growth %	-197.82	-221.7	71.66	-31.36	-
Net Income, 1 Yr. Growth %	-251.21	-180.19	115.69	-35.84	-341.5
Normalized Net Income, 1 Yr. Growth %	-66.79	43.62	370.55	-43.75	-347.36
Diluted EPS Before Extra, 1 Yr. Growth %	-251.12	-179.59	105.34	-33.8	-351.16
Accounts Receivable, 1 Yr. Growth %	0.3	7.44	-7.34	5.98	-
Net Property, Plant and Equip., 1 Yr. Growth %	-2.88	-15.35	-3.69	11.46	-
Total Assets, 1 Yr. Growth %	2.1	-1.27	-3.77	-1.9	-
Tangible Book Value, 1 Yr. Growth %	9.37	0.23	-4.36	-8.58	-
Common Equity, 1 Yr. Growth %	-22.74	-2.59	9	16.05	-
Cash From Operations, 1 Yr. Growth %	-1.03	-1.56	3.43	-6.79	-51.7
Capital Expenditures, 1 Yr. Growth %	-3.58	10.86	9.79	52.58	-
Levered Free Cash Flow, 1 Yr. Growth %	29	-86.85	39.87	-11.06	-
Unlevered Free Cash Flow, 1 Yr. Growth %	24.91	-71.73	29.59	-7.3	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.03	5.63	5.82	1.47	-
Gross Profit, 2 Yr. CAGR %	15.7	5.71	5.23	-0.2	-
EBITDA, 2 Yr. CAGR %	6.23	8.05	5.13	-0.31	-
EBITA, 2 Yr. CAGR %	1.79	8.72	5.74	-0.96	-
EBIT, 2 Yr. CAGR %	1.79	8.72	5.74	-0.96	-
Earnings From Cont. Operations, 2 Yr. CAGR %	-15.38	9.11	44.53	8.55	-
Net Income, 2 Yr. CAGR %	5.12	10.12	31.51	17.64	24.48
Normalized Net Income, 2 Yr. CAGR %	-42.58	-33.63	159.96	94.44	111.25
Diluted EPS Before Extra, 2 Yr. CAGR %	7.1	9.67	25.32	16.6	71.77
Accounts Receivable, 2 Yr. CAGR %	69.83	3.81	-0.22	-0.9	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.83	-9.33	5.37	-9.41	-
Total Assets, 2 Yr. CAGR %	6.49	0.4	-2.53	-2.84	-
Tangible Book Value, 2 Yr. CAGR %	13.34	4.7	-2.09	-6.5	-
Common Equity, 2 Yr. CAGR %	-11.77	-13.25	3.04	12.47	-
Cash From Operations, 2 Yr. CAGR %	3.82	-1.29	0.91	-1.81	-32.9
Capital Expenditures, 2 Yr. CAGR %	-0.85	3.39	10.32	29.43	-
Levered Free Cash Flow, 2 Yr. CAGR %	23.45	-59.23	-13.89	9.93	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.85	-41.04	-10.64	8.36	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.01	14.65	4.92	3.65	-
Gross Profit, 3 Yr. CAGR %	13.22	12.87	4.69	2.41	-
EBITDA, 3 Yr. CAGR %	6.99	7.45	5.25	3.07	-
EBITA, 3 Yr. CAGR %	4.26	4.92	5.52	3.13	-
EBIT, 3 Yr. CAGR %	4.26	4.92	5.52	3.13	-
Earnings From Cont. Operations, 3 Yr. CAGR %	-24.32	-4.48	26.9	12.77	-
Net Income, 3 Yr. CAGR %	-12.73	-3.95	37.78	3.53	49.51
Normalized Net Income, 3 Yr. CAGR %	-11.12	-24.1	27.5	58.58	37.13
Diluted EPS Before Extra, 3 Yr. CAGR %	-12.25	-2.99	35.17	1.31	-12.17
Accounts Receivable, 3 Yr. CAGR %	40.56	45.79	-0.05	1.8	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.77	-5.92	2.54	-1.83	-
Total Assets, 3 Yr. CAGR %	3.99	3.84	-1.01	-2.32	-
Tangible Book Value, 3 Yr. CAGR %	9.32	8.79	1.59	-4.31	-
Common Equity, 3 Yr. CAGR %	-8.76	-8.81	-6.39	7.21	-
Cash From Operations, 3 Yr. CAGR %	1.33	2	0.26	-1.73	-22.49
Capital Expenditures, 3 Yr. CAGR %	6.71	2.91	5.48	22.92	-
Levered Free Cash Flow, 3 Yr. CAGR %	10.1	-41.05	-2.12	-14.06	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.02	-25.07	-0.61	-10.43	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.05	11.64	10.66	9.18	-
Gross Profit, 5 Yr. CAGR %	13.29	11.92	9.87	7.45	-
EBITDA, 5 Yr. CAGR %	10.77	8.97	6.1	4.18	-
EBITA, 5 Yr. CAGR %	10.32	7.64	4.65	2.4	-
EBIT, 5 Yr. CAGR %	10.32	7.64	4.65	2.4	-
Earnings From Cont. Operations, 5 Yr. CAGR %	10.17	5.9	-1.97	0.53	-
Net Income, 5 Yr. CAGR %	23.6	7.72	2.83	4.16	32.3
Normalized Net Income, 5 Yr. CAGR %	-11.11	-10.63	34.38	3.96	-3.56
Diluted EPS Before Extra, 5 Yr. CAGR %	-	7.75	2	4.41	-4.01
Accounts Receivable, 5 Yr. CAGR %	23.38	26.49	22.55	24.93	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.41	-3.53	1.64	-1.43	-
Total Assets, 5 Yr. CAGR %	3.51	3.21	1.33	1.11	-
Tangible Book Value, 5 Yr. CAGR %	3.71	4.48	4.6	2.4	-
Common Equity, 5 Yr. CAGR %	-2.98	-4.44	-4.21	-0.83	-
Cash From Operations, 5 Yr. CAGR %	9.5	2.14	1.16	0.46	-14.62
Capital Expenditures, 5 Yr. CAGR %	20.99	13.5	8.14	12.8	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-27.01	0.24	-0.22	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-15.34	1.61	1.34	-